Loring Wolcott & Coolidge Fiduciary Advisors LLP Dexcom Inc Transaction History
Loring Wolcott & Coolidge Fiduciary Advisors LLP
- $11.2 Billion
- Q3 2025
A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Dexcom Inc stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 1,988 shares of DXCM stock, worth $115,423. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,988
Previous 1,988
-0.0%
Holding current value
$115,423
Previous $173,000
23.12%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding DXCM
# of Institutions
1,089Shares Held
442MCall Options Held
6.78MPut Options Held
7.25M-
Paul Tudor Jones Tudor Investment Corp Et Al | Stamford, Ct69.2MShares$4.01 Billion2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA49.5MShares$2.87 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.9MShares$979 Million0.04% of portfolio
-
Baillie Gifford & CO15.9MShares$922 Million0.84% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $22.4B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...